Merck’s new RSV treatment shows promise in protecting infants during trials, hinting at forthcoming approval
In a significant development in pediatric healthcare, Merck recently announced positive trial results for its innovative treatment against respiratory syncytial virus (RSV), which has demonstrated protective effects on newborns. This…